SITC 2019 General Registration Now Open!New session, presentation and speaker information now available!
SITC Cancer Immunotherapy Guidelines – Free Squamous Cell Carcinoma of the Head and Neck Webinar"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)"
JITC Increases Impact Factor to 8.676The Journal for ImmunoTherapy of Cancer (JITC), SITC’s open access, peer-reviewed online journal, has increased its impact factor to 8.676.
Now Available: SITC Cancer Immunotherapy Guidelines – Squamous cell carcinoma of the head and neck (HNSCC)Learn up-to-date consensus recommendations for immunotherapy of head and neck cancers in this recently published SITC Cancer Immunotherapy Guidelines manuscript.
REGISTER TODAYJoin SITC for two back-to-back immuno-oncology workshops.Sept. 4 - 6, 2019 | Houston, Texas
NOW AVAILABLE: SITC's Guide to Managing Immunotherapy Toxicity A new handbook from SITC for clinicians providing thorough coverage of the toxicity and management of adverse events for immune checkpoint inhibitors.
Winter School Enduring Materials Now Available to Public
Presentations from the 2019 Cancer Immunotherapy Winter School hosted Feb. 18–22, 2019, are now available to the general public.
Submit an abstract for SITC 2019 Submit a regular abstract, Young Investigator Award abstract and/or late-breaking abstract application by 5 p.m. PDT on Aug. 1, 2019.
Join Patrick Hwu, MD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.
Inspire the Next Generation of Cancer Immunotherapy Leaders
Advance the science of cancer immunotherapy and help young investigators tackle hurdles facing the field with a gift to the SITC Forward Fund.
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
Multiplex Immunofluorescence in Immune Oncology
Four Day Symposium and Workshop program divided into a lectures series given by world class scientists specializing ...
I think this is a great idea! I am not at the motherhood stage of my life yet but I know I am always interested to see organizations supporting mothers! I've been reading stories of women in science and how they balance motherhood and one woman talked ...
I could not agree with you more! I will pass this idea on. Priscila Gonalves, MD Assistant Professor Associate Director, Center for Novel Cancer Therapies (CNCT) Division of Medical Oncology and Hematology Northwell Health Cancer ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org